Alexion Pharmaceuticals (ALXN)

Add to Watchlists
Create an Alert
190.29 +4.37  +2.35% NASDAQ Oct 24, 8:00PM BATS Real time Currency in USD

Alexion Pharmaceuticals Retained Earnings (Quarterly):

704.95M for June 30, 2014

View 4,000+ financial data types

View Full Chart

Alexion Pharmaceuticals Retained Earnings (Quarterly) Chart

Export Data
Save Image

Alexion Pharmaceuticals Historical Retained Earnings (Quarterly) Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 704.95M
March 31, 2014 538.45M
Dec. 31, 2013 379.10M
Sept. 30, 2013 398.09M
June 30, 2013 304.30M
March 31, 2013 208.42M
Dec. 31, 2012 126.20M
Sept. 30, 2012 45.23M
June 30, 2012 -46.95M
March 31, 2012 -83.21M
Dec. 31, 2011 -128.62M
Sept. 30, 2011 -176.79M
June 30, 2011 -242.36M
March 31, 2011 -277.10M
Dec. 31, 2010 -303.93M
Sept. 30, 2010 -330.38M
June 30, 2010 -358.26M
March 31, 2010 -380.03M
Dec. 31, 2009 -400.96M
Sept. 30, 2009 -638.09M
June 30, 2009 -664.82M
March 31, 2009 -681.62M
Dec. 31, 2008 -696.13M
Sept. 30, 2008 -711.47M
June 30, 2008 -731.15M
   
March 31, 2008 -733.53M
Dec. 31, 2007 -729.28M
Sept. 30, 2007 -716.95M
June 30, 2007 -696.87M
March 31, 2007 -669.68M
Dec. 31, 2006 -637.58M
Sept. 30, 2006 -598.33M
June 30, 2006 -566.46M
March 31, 2006 -533.29M
Oct. 31, 2005 -483.18M
July 31, 2005 -448.11M
April 30, 2005 -415.47M
Jan. 31, 2005 -383.02M
Oct. 31, 2004 -358.55M
July 31, 2004 -339.36M
April 30, 2004 -319.24M
Jan. 31, 2004 -304.02M
Oct. 31, 2003 -285.48M
July 31, 2003 -265.27M
April 30, 2003 -243.68M
Jan. 31, 2003 -223.90M
Oct. 31, 2002 -202.44M
July 31, 2002 -180.80M
April 30, 2002 -159.96M
Jan. 31, 2002 -142.86M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Retained Earnings

The net income that remains after paying dividends. It is reported on the balance sheet as the cumulative sum of each year's retained earnings over the life of the business. Retained earnings can be used to pay debt and future dividends, or can be reinvested into business activities.

The "retained" refers to the earnings after paying out dividends. Companies with increasing retained earnings is good, because it means the company is staying consistently profitable. If a company has a yearly loss, this number is subtracted from retained earnings.

If a company's annual net income was 5 million, paid out 3 million in dividends, and had a retained earnings of 9 million, retained earnings at the end of 2012 would be 11 million (5-3+9). Similarly if next year the company paid no dividends but had a yearly net income loss of 5 million, retained earnings would be 6 million (11-5).
Learn More

Get data for
Advertisement

ALXN Retained Earnings (Quarterly) Benchmarks

Companies
Gilead Sciences 10.20B
Vertex Pharmaceuticals -4.359B
Biogen Idec 8.400B

ALXN Retained Earnings (Quarterly) Range, Past 5 Years

Minimum -400.96M Dec 2009
Maximum 704.95M Jun 2014
Average -1.255M

ALXN Retained Earnings (Quarterly) Excel Add-In Codes

  • Metric Code: retained_earnings
  • Latest data point: =YCP("ALXN", "retained_earnings")
  • Last 5 data points: =YCS("ALXN", "retained_earnings", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.